RPRX Relative Value & Intrinsic Value
Best stock ideas on the market right now
With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Low P/E stocks
Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
RPRX Valuation Multiples comparison vs Peer Set
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
RPRX Valuation multiples overview
RPRX Valuation multiples history vs. Peer set
Explore more intrinsic value tools hub for RPRX
FAQ
What is Royalty Pharma plc relative value?
As of Mar 03, 2025, Apple Relative Value is $60.2. This suggests it may be overvalued by 77.8% compared to its current price of around $33.9.
What is Royalty Pharma plc DCF (discounted cash flow) valuation?
As of Mar 03, 2025, Royalty Pharma plc's Discounted Cash Flow (DCF) valuation estimates its share price at $299.4. This suggests it may be overvalued by 784.5% to its current price of around $33.9, using a discount rate of 7.4% and terminal growth rate of 3.0%.
What is Royalty Pharma plc intrinsic value?
As of Mar 03, 2025, Apple Intrinsic Value is $179.7. This suggests it may be undervalued by 430.9% compared to its current price of around $33.9.